Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov 30;14(23):5086.
doi: 10.3390/nu14235086.

The Effects of Dietary Interventions on Brain Aging and Neurological Diseases

Affiliations
Review

The Effects of Dietary Interventions on Brain Aging and Neurological Diseases

Fleur Lobo et al. Nutrients. .

Abstract

Dietary interventions can ameliorate age-related neurological decline. Decades of research of in vitro studies, animal models, and clinical trials support their ability and efficacy to improve behavioral outcomes by inducing biochemical and physiological changes that lead to a more resilient brain. Dietary interventions including calorie restriction, alternate day fasting, time restricted feeding, and fasting mimicking diets not only improve normal brain aging but also slow down, or even reverse, the progression of neurological diseases. In this review, we focus on the effects of intermittent and periodic fasting on improving phenotypic outcomes, such as cognitive and motor-coordination decline, in the normal aging brain through an increase in neurogenesis and synaptic plasticity, and decrease in neuroinflammation, mitochondrial dysfunction, and oxidative stress. We summarize the results of various dietary interventions in animal models of age-related neurological diseases such as Alzheimer's disease, Parkinson's disease, epilepsy, and Multiple Sclerosis and discuss the results of clinical trials that explore the feasibility of dietary interventions in the prevention and treatment of these diseases.

Keywords: Alzheimer’s; Parkinson’s; aging; brain; epilepsy; intermittent fasting; multiple sclerosis; neurological diseases; periodic fasting.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Summary of reviewed findings in animal and human studies of AD, PD, epilepsy, and MS. PF: periodic fasting; IF: intermittent fasting; CR: caloric restriction; DR: dietary restriction; KD: ketogenic diet; Aβ: amyloid beta; SN: substantia nigra.

Similar articles

Cited by

References

    1. Arvanitakis Z., Shah R.C., Bennett D.A. Diagnosis and Management of Dementia: Review. JAMA. 2019;322:1589–1599. doi: 10.1001/jama.2019.4782. - DOI - PMC - PubMed
    1. 2022 Alzheimer’s disease facts and figures. Alzheimers Dement. 2022;18:700–789. doi: 10.1002/alz.12638. - DOI - PubMed
    1. Aarsland D., Kurz M.W. The epidemiology of dementia associated with Parkinson disease. J. Neurol. Sci. 2010;289:18–22. doi: 10.1016/j.jns.2009.08.034. - DOI - PubMed
    1. Ryman S.G., Yutsis M., Tian L., Henderson V.W., Montine T.J., Salmon D.P., Galasko D., Poston K.L. Cognition at Each Stage of Lewy Body Disease with Co-occurring Alzheimer’s Disease Pathology. J. Alzheimers Dis. 2021;80:1243–1256. doi: 10.3233/JAD-201187. - DOI - PMC - PubMed
    1. Kim W.S., Kågedal K., Halliday G.M. Alpha-synuclein biology in Lewy body diseases. Alzheimers Res. Ther. 2014;6:73. doi: 10.1186/s13195-014-0073-2. - DOI - PMC - PubMed